Cancer Incidence and Mortality among Black Individuals, New York County (Manhattan), 2016-2020
Source: New York State Cancer Registry
| Site of Cancer | Incidence | Mortality | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Males and Females | Males | Females | Males and Females | Males | Females | |||||||||||||
| Average Annual Cases | Rate per 100,000 Population | 95% CI | Average Annual Cases | Rate per 100,000 Males | 95% CI | Average Annual Cases | Rate per 100,000 Females | 95% CI | Average Annual Deaths | Rate per 100,000 Population | 95% CI | Average Annual Deaths | Rate per 100,000 Males | 95% CI | Average Annual Deaths | Rate per 100,000 Females | 95% CI | |
| All Invasive Malignant Tumors | 1,672.4 | 445.8 | 436.1-455.7 | 799.0 | 518.3 | 502.0-535.0 | 873.4 | 404.7 | 392.4-417.3 | 516.8 | 133.8 | 128.6-139.2 | 240.6 | 164.2 | 154.9-173.9 | 276.2 | 117.1 | 110.9-123.7 |
| Oral cavity and pharynx | 34.8 | 9.3 | 8.0-10.9 | 23.2 | 14.8 | 12.2-17.9 | 11.6 | 5.5 | 4.2-7.2 | 8.2 | 2.1 | 1.5-2.9 | 4.4 | 3.0 | 1.8-4.5 | 3.8 | 1.6 | 0.9-2.5 |
| Esophagus | 12.8 | 3.3 | 2.5-4.2 | 6.8 | 4.3 | 3.0-6.1 | 6.0 | 2.6 | 1.8-3.8 | 8.4 | 2.2 | 1.6-2.9 | 4.0 | 2.6 | 1.6-4.1 | 4.4 | 1.8 | 1.2-2.9 |
| Stomach | 32.0 | 8.6 | 7.3-10.1 | 16.6 | 11.1 | 8.8-13.8 | 15.4 | 6.9 | 5.4-8.7 | 13.8 | 3.6 | 2.8-4.5 | 7.4 | 4.7 | 3.3-6.5 | 6.4 | 2.6 | 1.8-3.8 |
| Colorectal | 141.2 | 37.8 | 35.0-40.8 | 73.0 | 48.9 | 43.9-54.3 | 68.2 | 30.7 | 27.4-34.2 | 49.4 | 12.9 | 11.3-14.7 | 26.0 | 18.2 | 15.1-21.7 | 23.4 | 9.4 | 7.8-11.4 |
| Colon excluding rectum | 99.4 | 26.5 | 24.2-29.0 | 49.6 | 33.3 | 29.2-37.8 | 49.8 | 22.2 | 19.5-25.3 | 37.0 | 9.7 | 8.4-11.3 | 18.0 | 12.7 | 10.2-15.7 | 19.0 | 7.7 | 6.2-9.5 |
| Rectum & rectosigmoid | 41.8 | 11.3 | 9.8-13.0 | 23.4 | 15.6 | 12.8-18.7 | 18.4 | 8.4 | 6.8-10.4 | 12.4 | 3.2 | 2.4-4.2 | 8.0 | 5.4 | 3.9-7.5 | 4.4 | 1.7 | 1.0-2.7 |
| Liver / intrahepatic bile duct | 59.2 | 14.9 | 13.2-16.7 | 40.2 | 24.9 | 21.5-28.7 | 19.0 | 8.1 | 6.5-10.0 | 30.0 | 7.7 | 6.5-9.1 | 19.0 | 12.6 | 10.2-15.5 | 11.0 | 4.6 | 3.5-6.1 |
| Pancreas | 58.8 | 15.1 | 13.4-16.9 | 27.8 | 18.1 | 15.2-21.5 | 31.0 | 13.1 | 11.1-15.4 | 44.2 | 11.2 | 9.8-12.8 | 19.4 | 12.9 | 10.4-15.8 | 24.8 | 10.2 | 8.4-12.2 |
| Larynx | 13.2 | 3.3 | 2.6-4.3 | 10.0 | 6.2 | 4.6-8.3 | 3.2 | 1.4 | 0.8-2.3 | 4.2 | 1.0 | 0.6-1.6 | 3.0 | 1.8 | 1.0-3.1 | 1.2 | 0.5 | 0.2-1.1 |
| Lung and bronchus | 191.2 | 49.6 | 46.4-52.9 | 91.2 | 60.4 | 54.9-66.4 | 100.0 | 42.7 | 39.0-46.7 | 97.0 | 24.8 | 22.6-27.2 | 48.8 | 32.6 | 28.6-37.1 | 48.2 | 20.1 | 17.6-22.9 |
| Melanoma of the skin | 5.8 | 1.6 | 1.1-2.4 | 2.0 | 1.4 | 0.6-2.5 | 3.8 | 1.8 | 1.1-2.9 | 0.8 | 0.2 | 0.1-0.6 | 0.2 | 0.1 | 0.0-0.8 | 0.6 | 0.2 | 0.0-0.8 |
| Female breast | 260.0 | 126.4 | 119.4-133.7 | 47.8 | 21.0 | 18.3-24.0 | ||||||||||||
| Cervix uteri | 19.4 | 9.8 | 7.9-12.1 | 6.8 | 3.3 | 2.2-4.7 | ||||||||||||
| Corpus uterus and NOS | 78.0 | 34.7 | 31.3-38.4 | 17.4 | 7.4 | 5.9-9.2 | ||||||||||||
| Ovary | 18.2 | 8.8 | 7.0-10.9 | 11.8 | 5.1 | 3.8-6.6 | ||||||||||||
| Prostate | 266.6 | 166.2 | 157.2-175.6 | 41.8 | 29.8 | 25.9-34.2 | ||||||||||||
| Testis | 5.4 | 3.3 | 2.1-4.9 | 0.2 | 0.1 | 0.0-0.8 | ||||||||||||
| Urinary bladder (incl. in situ) | 50.0 | 13.2 | 11.6-15.0 | 31.0 | 21.6 | 18.3-25.4 | 19.0 | 8.2 | 6.6-10.1 | 11.6 | 2.9 | 2.2-3.8 | 6.6 | 4.9 | 3.3-6.8 | 5.0 | 1.9 | 1.2-2.8 |
| Kidney and renal pelvis | 58.8 | 15.7 | 13.9-17.6 | 34.8 | 22.0 | 18.8-25.6 | 24.0 | 11.2 | 9.2-13.5 | 7.8 | 2.0 | 1.4-2.8 | 3.2 | 2.2 | 1.3-3.6 | 4.6 | 2.0 | 1.2-3.0 |
| Brain and other central nervous system | 14.2 | 4.1 | 3.2-5.3 | 7.2 | 4.9 | 3.4-6.8 | 7.0 | 3.6 | 2.5-5.1 | 7.6 | 2.0 | 1.4-2.8 | 4.8 | 3.0 | 1.9-4.6 | 2.8 | 1.3 | 0.7-2.2 |
| Thyroid | 35.6 | 10.4 | 8.9-12.1 | 8.2 | 5.2 | 3.7-7.1 | 27.4 | 15.0 | 12.5-17.8 | 1.0 | 0.3 | 0.1-0.6 | 0.4 | 0.3 | 0.0-1.1 | 0.6 | 0.2 | 0.0-0.8 |
| Hodgkin lymphoma | 12.0 | 3.6 | 2.7-4.7 | 6.4 | 4.5 | 3.1-6.4 | 5.6 | 3.0 | 2.0-4.4 | 0.2 | 0.1 | 0.0-0.3 | 0.2 | 0.1 | 0.0-0.7 | 0.0 | 0.0 | 0.0-0.5 |
| Non-Hodgkin lymphomas | 65.6 | 18.2 | 16.2-20.3 | 33.8 | 22.8 | 19.4-26.6 | 31.8 | 15.0 | 12.7-17.7 | 13.0 | 3.5 | 2.7-4.6 | 7.6 | 5.5 | 3.9-7.6 | 5.4 | 2.3 | 1.5-3.5 |
| Myeloma | 46.2 | 12.4 | 10.8-14.2 | 21.0 | 14.3 | 11.6-17.4 | 25.2 | 11.0 | 9.1-13.2 | 13.0 | 3.3 | 2.5-4.3 | 5.2 | 3.4 | 2.2-5.1 | 7.8 | 3.3 | 2.3-4.5 |
| Leukemias | 36.6 | 10.3 | 8.8-11.9 | 18.2 | 12.5 | 10.0-15.4 | 18.4 | 8.8 | 7.0-10.9 | 15.8 | 4.3 | 3.4-5.5 | 6.8 | 4.8 | 3.3-6.8 | 9.0 | 4.1 | 3.0-5.6 |
Notes
- Incidence data are provisional, November 2022.
- Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
- Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.
- NYSCR mortality statistics might differ slightly from official mortality statistics due to the availability of additional demographic information.
